Literature DB >> 23392681

Persistent receptor activity underlies group I mGluR-mediated cellular plasticity in CA3 neuron.

Steven R Young1, Shih-Chieh Chuang, Wangfa Zhao, Robert K S Wong, Riccardo Bianchi.   

Abstract

Plastic changes in cortical activities induced by group I metabotropic glutamate receptor (mGluR) stimulation include epileptogenesis, expressed in vitro as the conversion of normal neuronal activity to persistent, prolonged synchronized (ictal) discharges. At present, the mechanism that maintains group I mGluR-induced plasticity is not known. We examined this issue using hippocampal slices from guinea pigs and mice. Agonist [(S)-3,5-dihydroxyphenylglycine (DHPG), 30-50 μm)] stimulation of group I mGluRs induces persistent prolonged synchronized (ictal-like) discharges in CA3 that are associated with three identified excitatory cellular responses-suppression of spike afterhyperpolarizations, activation of a voltage-dependent cationic current, and increase in neuronal input resistance. Persistent prolonged synchronized discharges and the underlying excitatory cellular responses maintained following induction were reversibly blocked by mGluR1 antagonists [(S)-+-α-amino-4-carboxy-2-methylbenzeneacetic acid (LY 367385), 50, 100 μm; CPCCOEt (hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester, 100 μm], and to a lesser extent by the mGluR5 antagonist MPEP [2-methyl-6-(phenylethynyl)pyridine hydrochloride, 50 μm]. Activation of persistent cellular responses to DHPG were unaffected by tetrodotoxin (0.5-1 μm) or perfusion with low Ca(2+)(0.2 mm)-Mn(2+)(0.5 mm) media-conditions that suppress endogenous glutamate release. The pharmacological profile of the blocking action of the group I mGluR antagonist MCPG [(RS)-α-methyl-4-carboxyphenylglycine, 50-500 μm] on persistent cellular responses was different from that on cellular responses directly activated by DHPG. These data indicate that transient stimulation of group I mGluRs alters receptor properties, rendering them persistently active in the absence of applied agonist or endogenous glutamate activation. Persistent receptor activities, primarily involving mGluR1, maintain excitatory cellular responses and emergent prolonged synchronized discharges.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392681      PMCID: PMC3711659          DOI: 10.1523/JNEUROSCI.3338-12.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+.

Authors:  Daisuke Tsuchiya; Naoki Kunishima; Narutoshi Kamiya; Hisato Jingami; Kosuke Morikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

2.  Voltage-dependent block by intracellular Mg2+ of N-methyl-D-aspartate-activated channels.

Authors:  J W Johnson; P Ascher
Journal:  Biophys J       Date:  1990-05       Impact factor: 4.033

Review 3.  Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics.

Authors:  Annette Gilchrist
Journal:  Trends Pharmacol Sci       Date:  2007-07-17       Impact factor: 14.819

4.  Sustained neuronal activity generated by glial plasticity.

Authors:  Tiina M Pirttimaki; Stephen D Hall; H Rheinallt Parri
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

5.  Epilepsy and EEG findings in males with fragile X syndrome.

Authors:  S A Musumeci; R J Hagerman; R Ferri; P Bosco; B Dalla Bernardina; C A Tassinari; G B De Sarro; M Elia
Journal:  Epilepsia       Date:  1999-08       Impact factor: 5.864

6.  Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts.

Authors:  Lisa R Merlin
Journal:  J Neurophysiol       Date:  2002-01       Impact factor: 2.714

7.  Native rat hippocampal 5-HT1A receptors show constitutive activity.

Authors:  Jean-Claude Martel; Anne-Marie Ormière; Nathalie Leduc; Marie-Bernadette Assié; Didier Cussac; Adrian Newman-Tancredi
Journal:  Mol Pharmacol       Date:  2006-12-13       Impact factor: 4.436

Review 8.  Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Authors:  Colleen M Niswender; P Jeffrey Conn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

9.  Activation switch in the transmembrane domain of metabotropic glutamate receptor.

Authors:  Masataka Yanagawa; Takahiro Yamashita; Yoshinori Shichida
Journal:  Mol Pharmacol       Date:  2009-04-27       Impact factor: 4.436

10.  Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, noncompetitive antagonist of the metabotropic glutamate 1 receptor.

Authors:  Pari Malherbe; Nicole Kratochwil; Frédéric Knoflach; Marie-Thérèse Zenner; James N C Kew; Claudia Kratzeisen; Hans P Maerki; Geo Adam; Vincent Mutel
Journal:  J Biol Chem       Date:  2002-12-30       Impact factor: 5.157

View more
  14 in total

1.  Metabotropic glutamate receptor 2 inhibits thalamically-driven glutamate and dopamine release in the dorsal striatum.

Authors:  Kari A Johnson; Yolanda Mateo; David M Lovinger
Journal:  Neuropharmacology       Date:  2017-01-31       Impact factor: 5.250

2.  Extracellular glutamate exposure facilitates group I mGluR-mediated epileptogenesis in the hippocampus.

Authors:  Wangfa Zhao; Shih-Chieh Chuang; Steven R Young; Riccardo Bianchi; Robert K S Wong
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

3.  Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model.

Authors:  Leeyup Chung; Alexandra L Bey; Aaron J Towers; Xinyu Cao; Il Hwan Kim; Yong-Hui Jiang
Journal:  Neurobiol Dis       Date:  2017-10-31       Impact factor: 5.996

4.  mGluR1 and mGluR5 Synergistically Control Cholinergic Synaptic Transmission in the Thalamic Reticular Nucleus.

Authors:  Yan-Gang Sun; Vanessa Rupprecht; Li Zhou; Rajan Dasgupta; Frederik Seibt; Michael Beierlein
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

5.  Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.

Authors:  A Vanessa Stempel; Alexander Stumpf; Hai-Ying Zhang; Tuğba Özdoğan; Ulrike Pannasch; Anne-Kathrin Theis; David-Marian Otte; Alexandra Wojtalla; Ildikó Rácz; Alexey Ponomarenko; Zheng-Xiong Xi; Andreas Zimmer; Dietmar Schmitz
Journal:  Neuron       Date:  2016-04-28       Impact factor: 17.173

6.  Group I metabotropic glutamate receptors generate two types of intrinsic membrane oscillations in hippocampal oriens/alveus interneurons.

Authors:  Gubbi Govindaiah; Young-Jin Kang; Hannah Elisabeth Smashey Lewis; Leeyup Chung; Ethan M Clement; Lazar John Greenfield; Edgar Garcia-Rill; Sang-Hun Lee
Journal:  Neuropharmacology       Date:  2018-06-28       Impact factor: 5.250

Review 7.  Sustained Activity of Metabotropic Glutamate Receptor: Homer, Arrestin, and Beyond.

Authors:  Geehoon Chung; Sang Jeong Kim
Journal:  Neural Plast       Date:  2017-11-21       Impact factor: 3.599

8.  Early-Onset Network Hyperexcitability in Presymptomatic Alzheimer's Disease Transgenic Mice Is Suppressed by Passive Immunization with Anti-Human APP/Aβ Antibody and by mGluR5 Blockade.

Authors:  Syed F Kazim; Shih-Chieh Chuang; Wangfa Zhao; Robert K S Wong; Riccardo Bianchi; Khalid Iqbal
Journal:  Front Aging Neurosci       Date:  2017-03-24       Impact factor: 5.750

9.  Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress.

Authors:  Abigail M Polter; Kelsey Barcomb; Rudy W Chen; Paige M Dingess; Nicholas M Graziane; Travis E Brown; Julie A Kauer
Journal:  Elife       Date:  2017-04-12       Impact factor: 8.140

10.  TNF-α increases the intrinsic excitability of cerebellar Purkinje cells through elevating glutamate release in Bergmann Glia.

Authors:  Hyun Geun Shim; Sung-Soo Jang; Seung Ha Kim; Eun Mi Hwang; Joo Ok Min; Hye Yun Kim; Yoo Sung Kim; Changhyeon Ryu; Geehoon Chung; YoungSoo Kim; Bo-Eun Yoon; Sang Jeong Kim
Journal:  Sci Rep       Date:  2018-08-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.